(provided by candidate): The binding of growth hormone (GH) to GH receptor (GHR) activates JAK2, which phosphorylates itself, GHR, and induces the activation of signaling pathways. JAK2 is required for the majority of GH-induced cellular activities. However, all proteins currently known to interact directly with JAK2 are regulatory in nature. I propose that JAK2 also interacts directly with signaling molecules. This lab has recently identified a number of autophosphorylation sites within JAK2. Since phosphorylated tyrosines are prime targets for the binding of signaling molecules with SH2 or PTB domains, phosphopeptides will be used to screen for JAK2 interacting proteins using the COLT assay. Any clones developed from this will then be verified in vivo and investigated for functional consequence of JAK2 interaction. These studies will provide insight into new GH signaling proteins, new GH signaling pathways, and potentially new cellular responses to GH that are responsible for the diverse actions of GH on body growth and metabolism. JAK2-signaling protein interactions identified may also provide insight into signaling pathways and cellular responses of the many other cytokine receptors that activate JAK2.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32DK067810-01
Application #
6791070
Study Section
Special Emphasis Panel (ZRG1-F06 (20))
Program Officer
Hyde, James F
Project Start
2004-07-01
Project End
2006-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
1
Fiscal Year
2004
Total Cost
$42,976
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Physiology
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109